Science Explorer Back to mapMap
Discussion
Company · Bresso · Italy

Newron Pharmaceuticals (Italy)

World rank, all time
#29,143
of 34,923
Rank in Italy
#662
of 743
Research works
196
▲ 177% vs 2018-21
Citations
14k
70.3 per fractional work
Top-10% rate
6.6%
all institutions 10.0%
vs its own fields
1.20×
1.00× is exactly expected
Open access
48%
world 40%
International
33%
world 18%

Which fields of science does Newron Pharmaceuticals (Italy) work in?

In all years, 46% of research at Newron Pharmaceuticals (Italy) is in Health Sciences, 44% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (16%). It does 2.7× the world's share of Life Sciences.

Health Sciences: 90 fractional works · 45.8% of its workMedicine: 84 fractional works · 43.0% of its workEpidemiology: 20 fractional works · 10.0% of its workInfectious Diseases: 14 fractional works · 7.1% of its workSurgery: 9 fractional works · 4.6% of its workPharmacology: 9 fractional works · 4.5% of its workPublic Health, Environmental and Occupational Health: 7 fractional works · 3.8% of its workNeurology: 4 fractional works · 1.9% of its workPsychiatry and Mental health: 4 fractional works · 1.8% of its workHepatology: 3 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 1.5% of its workPhysiology: 3 fractional works · 1.4% of its workOncology: 2 fractional works · 0.9% of its workHematology: 1 fractional works · 0.5% of its workImmunology and Allergy: 1 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 0.5% of its workDermatology: 1 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.3% of its workRheumatology: 1 fractional works · 0.3% of its workMicrobiology: 0 fractional works · 0.2% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.6% of its workVeterinary: 3 fractional works · 1.7% of its workSmall Animals: 3 fractional works · 1.7% of its workNursing: 1 fractional works · 0.6% of its workNutrition and Dietetics: 1 fractional works · 0.6% of its workHealth Professions: 1 fractional works · 0.4% of its workGeneral Health Professions: 1 fractional works · 0.4% of its workDentistry: 0 fractional works · 0.2% of its workLife Sciences: 86 fractional works · 44.1% of its workBiochemistry, Genetics and Molecular Biology: 44 fractional works · 22.5% of its workMolecular Biology: 25 fractional works · 12.8% of its workGenetics: 7 fractional works · 3.4% of its workEndocrinology: 6 fractional works · 3.2% of its workBiotechnology: 3 fractional works · 1.4% of its workMolecular Medicine: 1 fractional works · 0.6% of its workCell Biology: 1 fractional works · 0.4% of its workClinical Biochemistry: 1 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 31 fractional works · 16.0% of its workImmunology: 17 fractional works · 8.7% of its workMicrobiology: 13 fractional works · 6.6% of its workVirology: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 6 fractional works · 3.0% of its workCellular and Molecular Neuroscience: 4 fractional works · 2.0% of its workSensory Systems: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.6% of its workAgricultural and Biological Sciences: 4 fractional works · 2.2% of its workFood Science: 2 fractional works · 0.8% of its workPlant Science: 1 fractional works · 0.7% of its workAgronomy and Crop Science: 1 fractional works · 0.3% of its workAnimal Science and Zoology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.5% of its workPharmacology: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 14 fractional works · 7.0% of its workEnvironmental Science: 5 fractional works · 2.5% of its workEcology: 4 fractional works · 1.9% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.3% of its workEnvironmental Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 3 fractional works · 1.7% of its workOrganic Chemistry: 2 fractional works · 1.3% of its workSpectroscopy: 1 fractional works · 0.5% of its workEngineering: 3 fractional works · 1.5% of its workElectrical and Electronic Engineering: 1 fractional works · 0.6% of its workBiomedical Engineering: 1 fractional works · 0.3% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workMathematics: 1 fractional works · 0.5% of its workStatistics and Probability: 1 fractional works · 0.5% of its workMaterials Science: 1 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 6 fractional works · 3.1% of its workSocial Sciences: 2 fractional works · 1.1% of its workHealth: 2 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 2 fractional works · 0.9% of its workEconomics and Econometrics: 2 fractional works · 0.9% of its workPsychology: 1 fractional works · 0.7% of its workClinical Psychology: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 0.4% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKNewronPharmaceuticals…196fractional works, all years
Life Sciences44%Physical Sciences7%Health Sciences46%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine8443.0%
    2. Veterinary31.7%
    3. Nursing10.6%
    4. Health Professions10.4%
    5. Dentistry00.2%
    1. Biochemistry, Genetics and Molecular Biology4422.5%
    2. Immunology and Microbiology3116.0%
    3. Neuroscience63.0%
    4. Agricultural and Biological Sciences42.2%
    5. Pharmacology, Toxicology and Pharmaceutics10.5%
    1. Environmental Science52.5%
    2. Chemistry31.7%
    3. Engineering31.5%
    4. Mathematics10.5%
    5. Materials Science10.4%
    6. Computer Science00.2%
    7. Earth and Planetary Sciences00.1%
    8. Physics and Astronomy00.1%
    1. Social Sciences21.1%
    2. Economics, Econometrics and Finance20.9%
    3. Psychology10.7%
    4. Business, Management and Accounting10.4%
    5. Arts and Humanities00.1%
    6. Decision Sciences00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.90× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 8.24× its world share, 1 worksNeuroscienceEngineering: 1.27× its world share, 2 worksEngineeringEnvironmental Science: 0.18× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.34× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.53× its world share, 0 worksPhysics and AstronomyMedicine: 2.48× its world share, 4 worksMedicinePsychology: 3.90× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 8.2×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Neuroscience8.24×1 works
  2. Psychology3.90×1 works
  3. Medicine2.48×4 works
  4. Engineering1.27×2 works
  5. Biochemistry, Genetics and Molecular Biology0.90×0 works
  6. Physics and Astronomy0.53×0 works
  7. Materials Science0.34×0 works
  8. Environmental Science0.18×0 works

Who are the top researchers at Newron Pharmaceuticals (Italy)?

Ranked on the quality score, Laura Faravelli, Rodolfo Giuliani and Gabriella Romanò lead among researchers whose main affiliation is Newron Pharmaceuticals (Italy).

  1. 1 Laura Faravelli Italy · #2,408,770 worldwide 2.2k citations · 32 works
  2. 2 Rodolfo Giuliani Italy · #2,627,693 worldwide 837 citations · 19 works
  3. 3 Gabriella Romanò Italy · #3,700,725 worldwide 643 citations · 28 works
  4. 4 Giovanni Chinellato Italy · #5,391,033 worldwide 47 citations · 20 works
All ranked researchers at Newron Pharmaceuticals (Italy)

What are the most cited papers from Newron Pharmaceuticals (Italy)?

The most cited paper from Newron Pharmaceuticals (Italy) is "An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus" (Elisabetta Traggiai, Stephan Becker, Kanta Subbarao et al., 2004), with 710 citations. Next come "Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs" (608) and "Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen" (550).

Most cited papers
#PaperReleasedCitations
1 An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Elisabetta Traggiai, Stephan Becker, Kanta Subbarao et al. · Nature Medicine Open access 11 Jul 2004 710
2 Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs Claudia Binda, Jin Wang, Leonardo Pisani et al. · Journal of Medicinal Chemistry Open access 4 Oct 2007 608
3 Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen Domenico Maione et al. · Science Open access Jul 2005 550
4 Reverse vaccinology, a genome-based approach to vaccine development Rino Rappuoli · Vaccine Mar 2001 496
5 The mechanism of action of MF59 – An innately attractive adjuvant formulation Derek T. O’Hagan, Gary S. Ott, Ennio De Gregorio et al. · Vaccine Jun 2012 487
All 60 most cited papers, with filters and sorting

Which keywords describe research at Newron Pharmaceuticals (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Vaccine, Antimicrobial Resistance, Immunity, Clinical Management, Antibiotic Resistance and Inflammation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology52▲ 6.6×44 topics
  2. Pathogenesis34▲ 31×15 topics
  3. Vaccine19▲ 24×11 topics
  4. Antimicrobial Resistance18▲ 37×7 topics
  5. Immunity16▲ 25×4 topics
  6. Inflammation16▲ 3.5×24 topics
  7. Clinical Management15▲ 39×3 topics
  8. Antibiotic Resistance15▲ 18×5 topics
  9. Prevention11▲ 14×2 topics
  10. Molecular Mechanisms10▲ 29×2 topics
  11. Bacterial Meningitis10▲ 199×1 topic
  12. Neisseria meningitidis10▲ 199×1 topic
  13. Virulence Factors10▲ 28×5 topics
  14. Genomics9▲ 13×3 topics
  15. Virus9▲ 38×3 topics
  16. Clinical Practice Guidelines9▲ 8.1×2 topics
  17. Pandemic8▲ 9.1×5 topics
  18. Gastric Cancer8▲ 32×1 topic
  19. Helicobacter pylori8▲ 81×1 topic
  20. Vaccine Development8▲ 13×6 topics
  21. Antigen Presentation8▲ 39×2 topics
  22. Immune Response8▲ 6.4×14 topics
  23. Vaccination8▲ 51×2 topics
  24. Community-Acquired Pneumonia8▲ 94×1 topic
  25. Pneumococcal Conjugate Vaccine8▲ 94×1 topic
  26. Membrane Proteins7▲ 20×3 topics
  27. Innate Immunity7▲ 10×6 topics
  28. Healthcare-Associated Infections6▲ 27×3 topics
  29. Drug Discovery6▲ 8.0×5 topics
  30. Marine Natural Products6▲ 55×2 topics
  31. Antibodies6▲ 35×2 topics
  32. Vaccines6▲ 43×2 topics
  33. Genome Sequencing6▲ 16×2 topics
  34. Pathogenicity6▲ 32×2 topics
  35. Signal Transduction6▲ 12×3 topics
  36. Genomic Analysis6▲ 9.6×4 topics
  37. H1N16▲ 77×1 topic
  38. Influenza6▲ 58×1 topic
  39. Natural Products5▲ 16×2 topics
  40. Type III Secretion System5▲ 40×2 topics

Which research topics does Newron Pharmaceuticals (Italy) publish most on?

By volume in 2022-now: Schizophrenia research and treatment, Child and Adolescent Psychosocial and Emotional Development, Neuroscience and Neuropharmacology Research and Treatment of Major Depression.

  1. 1 Schizophrenia research and treatment Psychiatry and Mental health 2 works
  2. 2 Child and Adolescent Psychosocial and Emotional Development Clinical Psychology 1 works
  3. 3 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  4. 4 Treatment of Major Depression Pharmacology 1 works
  5. 5 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
  6. 6 Diet and metabolism studies Physiology 0 works
  7. 7 Islanding Detection in Power Systems Electrical and Electronic Engineering 0 works
  8. 8 Power Systems Fault Detection Control and Systems Engineering 0 works
  9. 9 Receptor Mechanisms and Signaling Molecular Biology 0 works
  10. 10 Modular Robots and Swarm Intelligence Mechanical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.3%not open51.7%

World: 40% of research is openly available.

with international co-authors33.0%domestic only67.0%

World: 18% is written across borders.

How has Newron Pharmaceuticals (Italy)'s research output changed?

Output in 2022-2025 was 177% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Newron Pharmaceuticals (Italy) as a percentage of every work published that year, 0.000035% in 2024.

still counting0.00050%0.0010%0.0015%Newron Pharmaceuticals (Italy)0.000014% in 20251990200020102020

Fractional works of Newron Pharmaceuticals (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Bresso

All research institutions in Bresso

Share Newron Pharmaceuticals (Italy)'s ranking

Newron Pharmaceuticals (Italy) on Science Explorer

A card with Newron Pharmaceuticals (Italy)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Newron Pharmaceuticals (Italy). Posts are plain text and can be reported.